Category: Licensing/Collaboration Deal Region: North America · United States Company: Arena Pharmaceuticals Inc

Pfizer buys Arena in $6.7bn deal to broaden immuno inflammatory portfolio

Pfizer buys Arena in $6.7bn deal to broaden immuno inflammatory portfolio
The cash deal includes Arena

Found this useful? Share it with your team.

Welcome Back Sign in to Continue

Don't Have an Account? Sign Up!
Forgot Password?

Create your Account!

Don't Have an Account? Sign Up!